Date of Award


Degree Type


Degree Name

Master of Science (MS)


Molecular Biology


Tumor cells are notorious for their ability to escape immune surveillance, but developments in the understanding of the tumor microenvironment and how the immune system can be re-activated in tumors have had significant clinical impact. Commercially available and experimental methods such as adoptive cellular therapy, cytokine stimulation, and immune checkpoint blockade are promising immunotherapies for a variety of cancers, including solid tumors and hematological malignancies. However, induction of persistent, long-term anti-tumor immunity after initial treatment is infamously difficult. as a result, scientists are searching for new approaches to improve established immunotherapies. by employing combination treatments or enhancing the functionality of cellular products prior to infusion, patients may experience better clinical outcomes through the development of more effective immunotherapies. This thesis reviews the function of the immune system in the tumor microenvironment and discusses how this knowledge is used within the field of tumor immunology to develop and enhance immunotherapy models.

Creative Commons License

Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Included in

Oncology Commons